Depression and Anxiety in Different Thyroid Function States

Abstract

Previous studies on hypothyroid subjects have indicated serious psychiatric symptoms affecting the patients’ quality of life. The present prospective cross-sectional study’s aim was to examine these symptoms in thyroid patients with different functional states. A total of 254 patients (age: 56 ± 14 years [mean ± standard deviation], 181 female, 73 male) referred to a hospital for radioiodine treatment of hyperthyroidism or for follow-up of differentiated thyroid cancer, respectively, were included. All patients underwent the twelve-item general health questionnaire, which is an instrument for detecting mood disturbances. Euthyroid and hyperthyroid patients did not differ significantly in their general health questionnaire score (11 ± 5 vs. 11 ± 7), nor did subclinical hyperthyroid (11 ± 6) or subclinical hypothyroid subjects (12 ± 5). In contrast, hypothyroid patients showed a significantly higher mean score (17 ± 7, p < 0.001, ANOVA). Binary logistic regression revealed that hypothyroidism increases age and gender-adjusted risk for critical mood deterioration by seven-fold. Thus, hypothyroidism represents a widely underestimated functional condition that may severely affect mental health.

Hypothyroidism · Radioisotope therapy · Thyroid neoplasms · Quality of life · General health questionnaire

References

• 1 Brownlie B E, Rae A M, Walshe J W, Wells J E. Psychoses associated with thyrotoxicosis - ‘thyrotoxic psychosis’. A report of 18 cases, with statistical analysis of incidence.  Eur J Endocrinol. 2000;  142 438-444
• 2 Burmeister L A, Ganguli M, Dodge H H, Toczek T, DeKosky S T, Nebes R D. Hypothyroidism and cognition: preliminary evidence for a specific defect in memory.  Thyroid. 2001;  11 1177-1185
• 3 Placidi G PA, Boldrini M, Patronelli A, Fiore E, Chiovato L, Perugi G, Marazziti D. Prevalence of psychiatric disorders in thyroid diseased patients.  Neuropsychobiology. 1998;  38 222-225
• 4 Dow K H, Ferrell B R, Anello C. Quality-of-live changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy.  Thyroid. 1997;  7 613-619
• 5 Goldberg D P, Rickels K, Downing R, Hesbacher P. A comparison of two psychiatric screening tests.  Br J Psychiatry. 1976;  129 61-67
• 6 Stansfeld S A, Fuhrer R, Shipley M J, Marmot M G. Work characteristics predict psychiatric disorder: prospective results from the Whitehall II study.  Occup Envir Med. 1999;  56 302-307
• 7 Goldberg D P, Gater R, Sartorius N, Ustun T B, Piccinelli M, Gureje O, Rutter C. The validity of two versions of the GHQ in the WHO study of mental illness in general health care.  Psychol Med. 1997;  27 191-197
• 8 Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment.  Eur J Cancer. 1994;  30A 37-40
• 9 Staner L, Duval F, Calvi-Gries F, Mokrani M C, Bailey P, Hode Y, Toussaint M, Luthringer R, Muzet A, Macher J P. Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder.  Prog Neuropsychopharmacol Biol Psychiatry. 2001;  25 535-547
• 10 Cole D P, Thase M E, Mallinger A G, Soares J C, Luther M A, Kupfer D J, Frank E. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function.  Am J Psychiatry. 2002;  159 116-121
• 11 Harris B, Othman S, Davies J A, Weppner G J, Richards C J, Newcombe R G, Lazarus J H, Parkes A B, Hall R, Phillips D I. Association between postpartum thyroid dysfunction and thyroid antibodies and depression.  Br Med J. 1992;  305 152-156
• 12 Kuijpens J L, Vader H L, Drexhage H A, Wiersinga W M, van Son M J, Pop V J. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum.  Eur J Endocrinol. 2001;  145 579-584
• 13 Harris B, Oretti R, Lazarus J H, Parkes A B, John R, Richards C J, Newcombe R G, Hall R. Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women.  Br J Psychiatry. 2002;  180 330